European exploitation of biotechnology - Do government policies help?

Nature Biotechnology

Volumn 18, Issue 6, 2000, Pages 605-608

  Senker, Jacqueline ^a   Enzing, Christien ^b   Joly, Pierre Benoît ^c   Reiss, Thomas ^d  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b TNO   (Netherlands)

^c UNIV GRENOBLE ALPES   (France)

^d FRAUNHOFER INSTITUTE FOR SYSTEMS AND INNOVATION RESEARCH ISI   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; EUROPE; FINANCIAL MANAGEMENT; GOVERNMENT; MEDICAL RESEARCH; POLICY; PRIORITY JOURNAL; SHORT SURVEY;

BIOTECHNOLOGY; EUROPE; FINANCING, GOVERNMENT; PUBLIC POLICY; RESEARCH SUPPORT;

EID: 0034095544     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/76439     Document Type: Short Survey

References (3)

1. Enzing, C. et al. J. Inventory of public biotechnology R&D programmes in Europe, Analytical Report, vol 1. (Office for Official Publications of the European Communities, Luxembourg, 1999). Volumes 2 and 3, containing national reports, will be published in 2000.
2. Databases vary widely in their estimates of the number of French biotechnology firms. An emerging consensus indicates there are about 80-100.
3. BioResearch Ireland. BioResearch Ireland review '97. Putting Ireland on the biotechnology map. (BRI, Dublin, Ireland, 1998).